Enteric neuropeptides in streptozotocin-diabetic rats; effects of insulin and aldose reductase inhibition

Journal of the Autonomic Nervous System

Volumn 58, Issue 3, 1996, Pages 163-169

  Belai, Abebech ^a   Calcutt, Nigel A ^b   Carrington, Anne L ^b   Diemel, Lara T ^b   Tomlinson, David R ^b   Burnstock, Geoffrey ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Aldose reductase inhibitor; Diabetes; Insulin; Myenteric plexus; Neuropeptides

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; GALANIN; INSULIN; INSULIN ZINC SUSPENSION; PONALRESTAT; STREPTOZOCIN; SUBSTANCE P; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; INTESTINE INNERVATION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029933920     PISSN: 01651838     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-1838(95)00129-8     Document Type: Article

References (34)

1. Adamo, M., Raizada, M.K. and Le Roith, D., Insulin and insulin-like growth factor receptors in the nervous system, Mol. Neurobiol., 3 (1989) 71-100.
2. Ballmann, M. and Conlon, J.M., Changes in the somatostatin, substance P and vasoactive intestinal polypeptide content of the gastrointestinal tract following streptozotocin-induced diabetes in the rat, Diabetologia, 28 (1985) 355-358.
3. Belai, A. and Bumstock, G., Changes in adrenergic and peptidergic nerves in the submucous plexus of streptozotocin-diabetic rat ileum, Gastroenterology, 98 (1990) 1427-1436.
4. Belai, A., Lincoln, J., Milner, P., Crowe, R., Loesch, A. and Burnstock, G., Enteric nerves in diabetic rats: Increase in vasoactive intestinal polypeptide but not substance P, Gastroenterology, 89 (1985) 967-976.
5. Belai, A., Lincoln, J. and Burnstock, G., Lack of release of vasoactive intestinal polypeptide and calcitonin gene-related peptide during electrical stimulation of enteric nerves in streptozotocin-diabetic rats, Gastroenterology, 93 (1987) 1034-1040.
6. Belai, A., Lincoln, J., Milner, P. and Burnstock, G., Progressive changes in adrenergic, serotonergic, and peptidergic nerves in proximal colon of streptozotocin-diabetic rats, Gastroenterology, 95 (1988) 1234-1241.
7. Belai, A., Lincoln, J., Milner, P. and Burnstock, G., Differential effect of streptozotocin-induced diabetes on the innervation of the ileam and distal colon, Gastroenterology, 100 (1991) 1024-1032.
8. Burnstock, G., Mirsky, R. and Belai, A., Reversal of nerve damage in streptozotocin-diabetic rats by acute application of insulin in vitro, Clin. Sci., 75 (1988) 629-635.
9. Calcutt, N.A., Ettlinger, C.B., Carrington, A.L., Diemel, L.T. and Tomlinson, D.R., Resistance to hypoxic conduction block in sciatic nerves of rats with streptozotocin-induced diabetes, J. Neurol. Sci., 103 (1991) 116-123.
10. Cowan, T., Haven, AJ. and Burnstock, G., Pontamine sky blue: a counterstain for background autofluorescence in catecholamine fluorescence and immunofluorescence histochemistry, Histochemistry, 82 (1985) 205-208.
11. 125I insulin-binding sites in the intestinal tract of the rat: an autoradiographic study, J. Physiol. (Lond.), 396 (1988) 152P.
12. Di Giulio, A.M., Tenconi, B., La Croix, R., Mantegazza, P., Cattabeni, F. and Gorio, A., Denervation and hyperinnervation in the nervous system of diabetic animals. I. The autonomic neuronal dystrophy of the gut, J. Neurosci. Res., 24 (1989) 355-361.
13. Diemel, L.T., Stevens, E.J., Willars, G.B. and Tomlinson, D.R., Depletion of substance P and calcitonin gene-related peptide in sciatic nerve of rats with experimental diabetes; effects of insulin and aldose reductase inhibition, Neurosci. Lett., 137 (1992) 253-256.
14. Dvornik, D., Aldose reductase inhibition, Biomedical Information Corporation (McGraw-Hill), New York, 1987.
15. Ekstrom, P.A.R. and Tomlinson, D.R., Impaired nerve regeneration in streptozotocin-diabetic rats. Effects of treatment with an aldose reductase inhibitor, J. Neurol. Sci., 93 (1989) 231-237.
16. Gabbay, K.H., Merola, L.O. and Field, R.A., Sorbitol pathway: presence in nerve and cord with substrate accumulation in diabetes, Science, 151 (1966) 209-210.
17. Greene, D.A., Lattimer, S.A. and Sima, A.A.F., Pathogenesis and prevention of diabetic neuropathy, Diabetes Metab. Rev., 4 (1988) 201-221.
18. Greene, D.A., Sima, A.A.F., Pfeifer, M.A. and Albers, J.W., Diabetic neuropathy, Annu. Rev. Med., 41 (1990) 303-317.
19. Ishii, D.N., Glazner, G.W., Wang, C. and Fernyhough, P., Neurotrophic effects and mechanism of insulin, insulin-like growth factors, and nerve growth factor in spinal cord and peripheral neurons. In: D. Le Roith and M.K. Raizada (Eds.), Molecular and Cellular Biology of Insulin-like Growth Factors and the Receptors, Plenum Pub. Corp., 1989, pp. 403-425.
20. Kwok, R.S.P. and Jurio, A.V., Facilitating effect of insulin on brain 5-hydroxytryptamine metabolism, Endocrinology, 45 (1987) 267-273.
21. Lincoln, J., Bokor, J.T., Crowe, R., Griffith, S.G., Haven, A.J. and Burnstock, G., Myenteric plexus in streptozotocin-treated rats. Neurochemical and histochemical evidence for diabetic neuropathy in the gut, Gastroenterology, 86 (1984) 654-661.
22. Lucas, P.D. and Qirbi, A., Tissue noradrenaline and polyol pathway in experimentally diabetic rats, Br. J. Pharmacol., 97 (1989) 347-352.
23. Lucas, P.D. and Sardar, A.M., Effects of diabetes on cholinergic transmission in two rat gut preparations, Gastroenterology, 100 (1991) 123-128.
24. Macaleb, M.L., Myers, R.R.D., Singer, G. and Willis, G., Hypothalamic norepinephrine in the rat during feeding and push pull perfusion with glucose, 2-DG or insulin, Am. J. Physiol., 236 (1979) 312-321.
25. Masson, E.A. and Boulton, A.J.M., Aldose reductase inhibitors in the treatment of diabetic neuropathy: A review of the rationale and clinical evidence, Drugs, 39 (1990) 190-202.
26. Rasch, R., Control of blood glucose levels in the streptozotocin diabetic rat using a long-acting heat-treated insulin, Diabetologia, 16 (1979) 185-190.
27. Recio-Pinto, E. and Ishii, D.N., Insulin and related growth factors: effects on the nervous system and mechanism for neurite growth and regeneration, Neurochem. Int., 12 (1988) 397-414.
28. Robinson, J.P., Willars, G.B., Tomlinson, D.R. and Keen, P., Axonal transport and tissue contents of substance P in rats with long-term streptozotocin-diabetes. Effects of the aldose reductase inhibitor 'statil', Brain Res., 426 (1987) 339-348.
29. Sauter, A., Goldstein, M., Engel, J. and Ueta, K., Effect of insulin on central catecholamines, Brain Res., 260 (1983) 330-333.
30. Schubert, D., La Corbiere, M., Klier, F.G. and Steinbach, J.H., The modulation of neurotransmitter synthesis by steroid hormones and insulin, Brain Res., 190 (1980) 67-79.
31. Tomlinson, D.R., Filliatreau, G., Figliomeni, B., Hassig, R., Di Giamberardino, L. and Willars, G.B., Proteins of slow axonal transport in sciatic motoneurones of rats with streptozotocin-induced diabetes or galactosaemia, Diabetes Res. Clin. Pract., 9 (1990) 15-21.
32. Tomlinson, D.R., Robinson, J.P., Willars, G.B. and Keen, P., Deficient axonal transport of substance P in streptozotocin-induced diabetic rats, Effects of sorbinil and insulin. Diabetes, 37 (1988) 488-493.
33. Tomlinson, D.R., Polyols and myo-inositol in diabetic neuropathy - of mice and men, Mayo Clin. Proc., 64 (1989) 1030-1033.
34. Watkins, P.J., Clinical observations and experiments in diabetic neuropathy, Diabetologia, 35 (1992) 2-11.